好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Optimizing the “Stroke Alert” Activation Protocol for Hospitalized Patients
Practice, Policy, and Ethics
P1 - Poster Session 1 (9:00 AM-5:00 PM)
452

To study the frequency of stroke mimics and analyze the predictive value of the 2CAN score for accurate diagnosis of stroke among in-patient stroke alerts.

The stroke alert (SA) process has standardized the diagnosis and management of acute stroke (AS) with prompt delivery of time-sensitive treatment and intervention.  For in-patients, the process may be suboptimal due to the high incidence of stroke mimics (SM), both medical or neurological  leading to delayed diagnosis and care. The 2CAN-score is a novel clinical tool with good sensitivity (92%) for identifying stroke among in-patients. We examined the frequency of SM and the predictive value of 2CAN score for diagnosis of AS among an in-patient cohort for whom SA was activated.

Consecutive in-patient SAs from August 2020-March 2021 at our tertiary care stroke center were reviewed. Demographic, historic and examination findings were used to calculate 2CAN- score (clinical deficits: speech abnormality, facial droop, and asymmetric arm weakness, recent cardiac procedure, history of atrial fibrillation, new admission < 24 hours), final diagnosis per brain CT/MRI were retrospectively collected. The positive predictive value (PPV) and negative predictive value (NPV) of 2CAN score > 2 for diagnosis of AS were estimated.

Of 157 in-patient SAs, 47 (29%) had confirmed stroke (39 ischemic, 8 ICH), 3 had TIA, 107 (68%) were SM. The most common SM diagnosis was encephalopathy (51%) followed by seizure (16%) and hypotension (10%). 2CAN score ≥2 showed high sensitivity (85%) and NPV (89%) for identifying stroke whereas PPV was low, 44%.

About two-thirds of in-patient SA occurred for SM. 2CAN score can be a sensitive tool to triage the hospitalized patients deemed low-risk for stroke for whom SA activation may not be warranted. Implementation of this tool can help optimize the process allowing appropriate diagnosis and management of conditions presenting as stroke mimics.

Authors/Disclosures
Lisa Surowiec, MD (Jackson Memorial Hospital)
PRESENTER
Dr. Surowiec has nothing to disclose.
Tyler K. Simons, MD Dr. Simons has nothing to disclose.
Oriana Tascione, MD (University of Miami) Dr. Tascione has nothing to disclose.
Leticia Tornes, MD, FAAN (University of Miami) Dr. Tornes has nothing to disclose.
Erika T. Marulanda, MD, FAAN (University of Miami) Dr. Marulanda has nothing to disclose.
Neeta Garg, MD (Harbor UCLA Medical Center) Dr. Garg has nothing to disclose.